非侵入性植入前遗传学检测非整倍体:进展更新
非整倍体在辅助生殖技术使用的植入前人类胚胎中常见,常规需行侵入性滋养层活检。胚胎在体外发育时向培养液分泌游离DNA,基于此的非侵入性检测与滋养层活检、内细胞团及整个囊胚高度一致,但信息量和一致率受培养液收集日、污染及胚胎先前操作影响。本综述讨论胚胎游离DNA作为生物标志物用于优先选择囊胚移植,并探讨其分泌机制。
要点
- 胚胎游离DNA检测与滋养层活检、内细胞团及全囊胚高度一致。
- 信息量和一致率受培养液收集日、外源及卵丘细胞DNA污染、胚胎先前操作影响。
- 胚胎游离DNA可用于优先选择囊胚移植,以帮助提高植入率、降低流产率和缩短妊娠时间。
核心结论
- 胚胎游离DNA分析可作为非侵入性生物标志物,用于优先选择囊胚移植,以帮助提高植入率、降低流产率和缩短妊娠时间。
研究设计与样本
- 综述,讨论非侵入性胚胎游离DNA分析作为非整倍体生物标志物的研究进展及游离DNA分泌机制。
主要发现
- 胚胎在体外发育过程中向培养液分泌游离DNA,提示可用于非侵入性非整倍体检测。
- 基于胚胎游离DNA的检测与滋养层活检、内细胞团及整个囊胚高度一致。
- 信息量和一致率可能受培养液收集日、外源及卵丘细胞DNA污染、胚胎先前操作影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 信息量和一致率可能受培养液收集日、外源及卵丘细胞DNA污染、胚胎先前操作影响。
- 原文提到需持续研究胚胎游离DNA分泌机制及其对非整倍体生物标志物作用的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aneuploidy is common among preimplantation human embryos used in assisted reproductive technology. Because abnormal chromosome number can negatively affect reproductive outcome, in-vitro-fertilized embryos routinely undergo aneuploidy testing before transfer into the uterus. This testing typically involves an invasive trophectoderm biopsy of a blastocyst-stage embryo. However, emerging evidence indicates that, during in-vitro development, embryos secrete cell-free DNA into their culture medium; this phenomenon suggests the potential for an alternative, non-invasive assay for aneuploidy. Embryonic cell-free DNA-based assays exhibit high concordance with trophectoderm biopsies, inner cell mass and the whole blastocyst. Yet informativity and concordance rates may be influenced by several factors: the culture day when the medium is collected, contamination with external and/or cumulus cell DNA, and previous manipulation of the embryos. This review discusses non-invasive embryonic cell-free DNA analysis as a biomarker to prioritize blastocysts for transfer to help increase implantation rates and reduce miscarriage rates and time to achieve pregnancy. Ongoing research on the mechanisms underlying embryonic cell-free DNA secretion and how this impacts its role as a biomarker of aneuploidy are also discussed.
引用
- Navarro-Sánchez L, García-Pascual C, Rubio C, et al. Non-invasive preimplantation genetic testing for aneuploidies: an update. Reprod Biomed Online. 2022. PMID: 35307298. doi:10.1016/j.rbmo.2022.01.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。